Trending Now
Agenus Inc. (NASDAQ:AGEN) To Commence Phase 2 Expansion Study Of AGEN1181...
Agenus Inc. (NASDAQ:AGEN) has expanded its Phase 2 study into colon cancer based on new objective clinical response in a patient with...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Progenity Inc. (NASDAQ:PROG) Announces Expansion Of COVID-19 RT-PCR Test In The...
Progenity Inc. (NASDAQ:PROG) has announced expanding the COVID-19 RT-PCR testing availability across the US to support the growing demand for coronavirus testing.
MAKE IT MODERN
LATEST REVIEWS
Pasithea Therapeutics Corp (NASDAQ: KTTA) Expands IV Ketamine Therapy Availability In...
Pasithea Therapeutics Corp (NASDAQ: KTTA) has announced that its wholly-owned subsidiary, Pasithea Clinics, has expanded the availability of IV ketamine therapy to Florida and...
MAKE IT MODERN
PERFORMANCE TRAINING
Longeveron Inc (NASDAQ: LGVN) Executes an Agreement With the United States Department of Veterans...
Longeveron Inc (NASDAQ: LGVN) recently announced the execution of a Cooperative Research and Development Agreement (CRADA) with the United States Department of Veterans Affairs....
Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) Announce Positive PHALCON-EE Study Results Of Vonoprazan in Erosive...
Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) announced that vonoprazan met the primary endpoints and core secondary superiority endpoints in PHALCON-EE, a vital third phase study...
Will Sarepta Therapeutics ($SRPT) shares hit 200$ by the end of the year ?
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) shares closed at $160.72, up by $37.22 (30.14%) at 4:00 PM EDT. In after-hours trading, the stock...
Inter & Co Inc (NASDAQ:INTR) bull rally may not subside and here’s why
Inter, a pioneering Brazilian company with its multifaceted "super app", has experienced a remarkable upward trajectory in its shares this year, sparking...
Progenity Inc. (NASDAQ: PROG) Shares Presentation Correlation Between Clinical Outcomes and Tissue Exposure in...
Progenity Inc. (NASDAQ: PROG) has shared an oral presentation delivered by Dr. Bram Verstockt at the 34th Belgian Week of Gastroenterology on February 9,...
MAKE IT MODERN
